| Product Code: ETC7223764 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 France Molecular Point of Care Testing (using NAAT) Market Overview |
3.1 France Country Macro Economic Indicators |
3.2 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, 2021 & 2031F |
3.3 France Molecular Point of Care Testing (using NAAT) Market - Industry Life Cycle |
3.4 France Molecular Point of Care Testing (using NAAT) Market - Porter's Five Forces |
3.5 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 France Molecular Point of Care Testing (using NAAT) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for rapid and accurate diagnostic solutions |
4.2.2 Growing prevalence of infectious diseases requiring quick detection and treatment |
4.2.3 Technological advancements in molecular point of care testing (using NAAT) |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of molecular point of care testing devices |
4.3.2 High costs associated with implementing and maintaining molecular point of care testing systems |
4.3.3 Limited awareness and adoption of molecular point of care testing in certain healthcare settings |
5 France Molecular Point of Care Testing (using NAAT) Market Trends |
6 France Molecular Point of Care Testing (using NAAT) Market, By Types |
6.1 France Molecular Point of Care Testing (using NAAT) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 France Molecular Point of Care Testing (using NAAT) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Respiratory Infections Testing, 2021- 2031F |
6.2.3 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Sexually Transmitted Infection (STI) Testing, 2021- 2031F |
6.2.4 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Gastrointestinal Tract Infections Testing, 2021- 2031F |
6.2.5 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 France Molecular Point of Care Testing (using NAAT) Market, By End users |
6.3.1 Overview and Analysis |
6.3.2 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.5 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Ambulatory Centers, 2021- 2031F |
6.3.6 France Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
7 France Molecular Point of Care Testing (using NAAT) Market Import-Export Trade Statistics |
7.1 France Molecular Point of Care Testing (using NAAT) Market Export to Major Countries |
7.2 France Molecular Point of Care Testing (using NAAT) Market Imports from Major Countries |
8 France Molecular Point of Care Testing (using NAAT) Market Key Performance Indicators |
8.1 Average turnaround time for test results |
8.2 Rate of adoption of molecular point of care testing in healthcare facilities |
8.3 Frequency of updates and improvements in molecular point of care testing technology |
9 France Molecular Point of Care Testing (using NAAT) Market - Opportunity Assessment |
9.1 France Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 France Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 France Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 France Molecular Point of Care Testing (using NAAT) Market - Competitive Landscape |
10.1 France Molecular Point of Care Testing (using NAAT) Market Revenue Share, By Companies, 2024 |
10.2 France Molecular Point of Care Testing (using NAAT) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here